Full Text
PMH38 A COST UTILITY ANALYSIS OF FIRST LINE ANTIPSYCHOTICS FOR THE PREVENTION OF SCHIZOPHRENIA RELAPSE IN THE UNITED KINGDOM

Abstract

Authors

MA Jones GC Meier

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×